Effects of Teriparatide in Postmenopausal Women With Osteoporosis
PHASE4
Effects of Teriparatide in Postmenopausal Women Previously Treated with Ale...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer
PHASE3
This is a global Phase III, two-arm, open-label, multicenter, randomized st...